WT1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes

Akosua B. Domfeh, Annamarie L. Carley, Joan M. Striebel, Rouzan G. Karabakhtsian, Anca V. Florea, Kim McManus, Sushil Beriwal, Rohit Bhargava

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Current literature suggests that strong WT1 expression in a carcinoma of unknown origin virtually excludes a breast primary. Our previous pilot study on WT1 expression in breast carcinomas has shown WT1 expression in approximately 10% of carcinomas that show mixed micropapillary and mucinous morphology (Mod Pathol 2007;20(Suppl 2):38A). To definitively assess as to what subtype of breast carcinoma might express WT1 protein, we examined 153 cases of invasive breast carcinomas. These consisted of 63 consecutive carcinomas (contained 1 mucinous tumor), 20 cases with micropapillary morphology (12 pure and 8 mixed), 6 micropapillary 'mimics' (ductal no special type carcinomas with retraction artifacts), 33 pure mucinous carcinomas and 31 mixed mucinous carcinomas (mucinous mixed with other morphologic types). Overall, WT1 expression was identified in 33 carcinomas, that is, 22 of 34 (65%) pure mucinous carcinomas and in 11 of 33 (33%) mixed mucinous carcinomas. The non-mucinous component in these 11 mixed mucinous carcinomas was either a ductal no special type carcinoma (8 cases) or a micropapillary component (3 cases). WT1 expression level was similar in both the mucinous and the non-mucinous components. The degree of WT1 expression was generally weak to moderate (>90% cases) and rarely strong (

Original languageEnglish (US)
Pages (from-to)1217-1223
Number of pages7
JournalModern Pathology
Volume21
Issue number10
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Mucinous Adenocarcinoma
Breast Neoplasms
Carcinoma
Artifacts
Breast
Neoplasms
Proteins

Keywords

  • Immunotherapy
  • Mucinous and micropapillary breast carcinoma
  • WT1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Domfeh, A. B., Carley, A. L., Striebel, J. M., Karabakhtsian, R. G., Florea, A. V., McManus, K., ... Bhargava, R. (2008). WT1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes. Modern Pathology, 21(10), 1217-1223. https://doi.org/10.1038/modpathol.2008.69

WT1 immunoreactivity in breast carcinoma : Selective expression in pure and mixed mucinous subtypes. / Domfeh, Akosua B.; Carley, Annamarie L.; Striebel, Joan M.; Karabakhtsian, Rouzan G.; Florea, Anca V.; McManus, Kim; Beriwal, Sushil; Bhargava, Rohit.

In: Modern Pathology, Vol. 21, No. 10, 10.2008, p. 1217-1223.

Research output: Contribution to journalArticle

Domfeh, AB, Carley, AL, Striebel, JM, Karabakhtsian, RG, Florea, AV, McManus, K, Beriwal, S & Bhargava, R 2008, 'WT1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes', Modern Pathology, vol. 21, no. 10, pp. 1217-1223. https://doi.org/10.1038/modpathol.2008.69
Domfeh, Akosua B. ; Carley, Annamarie L. ; Striebel, Joan M. ; Karabakhtsian, Rouzan G. ; Florea, Anca V. ; McManus, Kim ; Beriwal, Sushil ; Bhargava, Rohit. / WT1 immunoreactivity in breast carcinoma : Selective expression in pure and mixed mucinous subtypes. In: Modern Pathology. 2008 ; Vol. 21, No. 10. pp. 1217-1223.
@article{83f6a7b3e4704afc9f647836a8b22a3f,
title = "WT1 immunoreactivity in breast carcinoma: Selective expression in pure and mixed mucinous subtypes",
abstract = "Current literature suggests that strong WT1 expression in a carcinoma of unknown origin virtually excludes a breast primary. Our previous pilot study on WT1 expression in breast carcinomas has shown WT1 expression in approximately 10{\%} of carcinomas that show mixed micropapillary and mucinous morphology (Mod Pathol 2007;20(Suppl 2):38A). To definitively assess as to what subtype of breast carcinoma might express WT1 protein, we examined 153 cases of invasive breast carcinomas. These consisted of 63 consecutive carcinomas (contained 1 mucinous tumor), 20 cases with micropapillary morphology (12 pure and 8 mixed), 6 micropapillary 'mimics' (ductal no special type carcinomas with retraction artifacts), 33 pure mucinous carcinomas and 31 mixed mucinous carcinomas (mucinous mixed with other morphologic types). Overall, WT1 expression was identified in 33 carcinomas, that is, 22 of 34 (65{\%}) pure mucinous carcinomas and in 11 of 33 (33{\%}) mixed mucinous carcinomas. The non-mucinous component in these 11 mixed mucinous carcinomas was either a ductal no special type carcinoma (8 cases) or a micropapillary component (3 cases). WT1 expression level was similar in both the mucinous and the non-mucinous components. The degree of WT1 expression was generally weak to moderate (>90{\%} cases) and rarely strong (",
keywords = "Immunotherapy, Mucinous and micropapillary breast carcinoma, WT1",
author = "Domfeh, {Akosua B.} and Carley, {Annamarie L.} and Striebel, {Joan M.} and Karabakhtsian, {Rouzan G.} and Florea, {Anca V.} and Kim McManus and Sushil Beriwal and Rohit Bhargava",
year = "2008",
month = "10",
doi = "10.1038/modpathol.2008.69",
language = "English (US)",
volume = "21",
pages = "1217--1223",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - WT1 immunoreactivity in breast carcinoma

T2 - Selective expression in pure and mixed mucinous subtypes

AU - Domfeh, Akosua B.

AU - Carley, Annamarie L.

AU - Striebel, Joan M.

AU - Karabakhtsian, Rouzan G.

AU - Florea, Anca V.

AU - McManus, Kim

AU - Beriwal, Sushil

AU - Bhargava, Rohit

PY - 2008/10

Y1 - 2008/10

N2 - Current literature suggests that strong WT1 expression in a carcinoma of unknown origin virtually excludes a breast primary. Our previous pilot study on WT1 expression in breast carcinomas has shown WT1 expression in approximately 10% of carcinomas that show mixed micropapillary and mucinous morphology (Mod Pathol 2007;20(Suppl 2):38A). To definitively assess as to what subtype of breast carcinoma might express WT1 protein, we examined 153 cases of invasive breast carcinomas. These consisted of 63 consecutive carcinomas (contained 1 mucinous tumor), 20 cases with micropapillary morphology (12 pure and 8 mixed), 6 micropapillary 'mimics' (ductal no special type carcinomas with retraction artifacts), 33 pure mucinous carcinomas and 31 mixed mucinous carcinomas (mucinous mixed with other morphologic types). Overall, WT1 expression was identified in 33 carcinomas, that is, 22 of 34 (65%) pure mucinous carcinomas and in 11 of 33 (33%) mixed mucinous carcinomas. The non-mucinous component in these 11 mixed mucinous carcinomas was either a ductal no special type carcinoma (8 cases) or a micropapillary component (3 cases). WT1 expression level was similar in both the mucinous and the non-mucinous components. The degree of WT1 expression was generally weak to moderate (>90% cases) and rarely strong (

AB - Current literature suggests that strong WT1 expression in a carcinoma of unknown origin virtually excludes a breast primary. Our previous pilot study on WT1 expression in breast carcinomas has shown WT1 expression in approximately 10% of carcinomas that show mixed micropapillary and mucinous morphology (Mod Pathol 2007;20(Suppl 2):38A). To definitively assess as to what subtype of breast carcinoma might express WT1 protein, we examined 153 cases of invasive breast carcinomas. These consisted of 63 consecutive carcinomas (contained 1 mucinous tumor), 20 cases with micropapillary morphology (12 pure and 8 mixed), 6 micropapillary 'mimics' (ductal no special type carcinomas with retraction artifacts), 33 pure mucinous carcinomas and 31 mixed mucinous carcinomas (mucinous mixed with other morphologic types). Overall, WT1 expression was identified in 33 carcinomas, that is, 22 of 34 (65%) pure mucinous carcinomas and in 11 of 33 (33%) mixed mucinous carcinomas. The non-mucinous component in these 11 mixed mucinous carcinomas was either a ductal no special type carcinoma (8 cases) or a micropapillary component (3 cases). WT1 expression level was similar in both the mucinous and the non-mucinous components. The degree of WT1 expression was generally weak to moderate (>90% cases) and rarely strong (

KW - Immunotherapy

KW - Mucinous and micropapillary breast carcinoma

KW - WT1

UR - http://www.scopus.com/inward/record.url?scp=52549085333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52549085333&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2008.69

DO - 10.1038/modpathol.2008.69

M3 - Article

C2 - 18469795

AN - SCOPUS:52549085333

VL - 21

SP - 1217

EP - 1223

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 10

ER -